Related Experiment Video
Updated: Jan 3, 2026

Knee Arthrocentesis in Adults
Published on: February 25, 2022
Lower genital tract infections in young female juvenile idiopathic arthritis patients
Gabriela R V Ferreira1, Renato B Tomioka2,3, Ligia B Queiroz4
1Pediatric Rheumatology Unit, Children's Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Eneas Carvalho Aguiar, 647 - Cerqueira César, São Paulo, SP, 05403-000, Brazil.
Insights
Human papillomavirus (HPV) is the primary cause of cervical dysplasia in juvenile idiopathic arthritis (JIA) patients. Common infections like Chlamydia trachomatis and Neisseria gonorrhoeae were not significantly increased in JIA patients.
Area of Science:
- Gynecology
- Rheumatology
- Infectious Diseases
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disease affecting children and young adults.
- Lower genital tract infections, including human papillomavirus (HPV), Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), may pose risks to patients with chronic conditions.
- Understanding infection prevalence in JIA patients is crucial for managing their reproductive health.
Purpose of the Study:
- To investigate the prevalence of HPV, CT, and NG infections in female adolescent and young adult patients with JIA.
- To assess the association between these infections and cervical abnormalities in JIA patients.
- To evaluate the impact of JIA treatments on the risk of lower genital tract infections.
Main Methods:
- A cohort of 33 female JIA patients and 28 healthy controls underwent gynecological and sexual function assessments.
- Cervical specimens were tested for HPV-DNA, CT-DNA, and NG-DNA using Hybrid Capture 2 assays.
- Clinical and laboratory parameters, JIA treatments (methotrexate, biological agents), and cervical cytology were evaluated.
Main Results:
- HPV infection was more frequent in JIA patients (30%) compared to controls (11%), though not statistically significant (p=0.155).
- CT and NG infections were rare and similar between JIA patients and controls.
- JIA patients with abnormal cervical cytology showed a significantly higher HPV infection rate (87%) compared to those with normal cytology (12%) (p=0.0002).
- No significant differences in demographic data, sexual function, or JIA treatment modalities were observed between JIA subgroups with normal or abnormal cytology.
Conclusions:
- HPV is identified as the main cause of cervical dysplasia in JIA patients.
- Current JIA treatments, including methotrexate and biological agents, do not appear to increase the risk of lower genital tract infections.
- This study highlights the importance of screening for HPV in JIA patients to prevent cervical dysplasia.
Background:
To evaluate human papillomavirus (HPV), Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in juvenile idiopathic arthritis (JIA) patients.
Methods:
After exclusion, 33 female adolescent and young JIA patients (ILAR criteria) and 28 healthy controls were selected for this study. Demographic data, gynecological, sexual function, cervical cytology and histological abnormalities were evaluated. JIA clinical/laboratorial parameters and treatment were also assessed. HPV-DNA, CT-DNA and NG-DNA testing in cervical specimens were performed by Hybrid Capture 2 assays.
Results:
The mean current age was similar in JIA patients and controls (23.3 ± 6.24 vs. 26.1 ± 6.03 years, p = 0.09). The frequencies of sexual intercourse (76% vs. 89%, p = 0.201) and abnormal cervical cytology (24% vs. 11%, p = 0.201) were similar in JIA compared to controls. The higher frequency of HPV infection in JIA patients than controls (30% vs. 11%, p = 0.155) did not reach statistical significance. CT (0% vs. 7%, p = 0.207) and NG infections (0% vs. 4%, p = 0.459) were also alike in both groups. Further evaluation of JIA patients with abnormal and normal cervical cytology showed that the former group had a higher frequency of HPV infection (87% vs. 12%, p = 0.0002) with a low frequency of HPV vaccination (0% vs. 8%, p = 1.0). No differences were evidenced between these two JIA groups regarding demographic data, sexual function and clinical/laboratorial parameters. The frequencies of methotrexate (p = 0.206) and biological agent use (p = 0.238) were similar in both JIA groups.
Conclusions:
To our knowledge, this was the first study to assess lower genital infections in JIA patients allowing the identification of HPV as main cause of cervical dysplasia. Methotrexate and biological agents do not seem to increase risk of lower genital tract infections in JIA patients.
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis I: Introduction
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Acute Pyelonephritis II: Diagnostic Studies and Management

